Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis

NCT03000660 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped partial clinical hold per FDA

Conditions

AL Amyloidosis

Interventions

DRUG: Venetoclax
DRUG: Dexamethasone

Sponsor

Tufts Medical Center